Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Ptc Therapeutics Cmn (PTCT)

8.70 +0.06 (+0.69%)

3/29/2017  12:54pm

Open:

8.68

Pre. Close:

8.64

High:

8.85

Low:

8.65

Volume:

477,498

Market Cap:

297.27M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.97 - 9.18

9.18 - 9.44

Low:

7.98 - 8.17

8.17 - 8.43

Close:

8.2 - 8.5

8.5 - 8.89

Technical analysis  (as of: 2017-03-29 12:48:23 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 14.04     One year: 16.86

Support:

Support1: 8.12    Support2: 6.76

Resistance:

Resistance1: 12.02    Resistance2: 14.43

Pivot:

9.33

Moving Averages:

MA(5): 8.62     MA(20): 9.54

MA(100): 11.70     MA(250): 9.50

MACD:

MACD(12,26):     Signal(12,26,9): -0.99

%K %D:

%K(14,3): 20.30     %D(3): 17.95

RSI:

RSI(14): 35.42

52-Week:

High: 16.50  Low: 4.03  Change(%): 29.1

Average Vol(K):

3-Month: 1196  10-Days 1644

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PTCT has closed above bottom band by 33.8%. Bollinger Bands are 16.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 16 Mar 2017 20:40:36 GMT
Why PTC Therapeutics may have to lower the price on a $89000-a-year drug it ...

Thu, 16 Mar 2017 11:26:15 GMT
PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results ...

Tue, 28 Mar 2017 17:15:00 GMT
Is It Time to go for PTC Therapeutics, Inc. (PTCT), Amphenol Corporation (APH)?

Mon, 27 Mar 2017 15:56:15 GMT
Commit To Buy PTC Therapeutics At $8, Earn 26% Annualized Using Options

Mon, 06 Mar 2017 12:56:15 GMT
PTC Therapeutics Announces Timing Change for Fourth Quarter and Year End 2016 ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

34.36

Shares Float (M)

30.84

% Held by Insiders

20.88

% Held by Institutions

97.10

Shares Short (K)

4300

Shares Short Prior Month (K)

4100

Stock Financials

EPS

-4.170

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

3.500

PEG Ratio

0.25

Profit Margin

-171.83

Operating Margin

-156.77

Return on Assets (ttm)

-25.5

Return on Equity (ttm)

-82.2

Qtrly Rev. Growth

97.8

Gross Profit (p.s.)

2.407

Sales Per Share

2.407

EBITDA (p.s.)

-3.678

Qtrly Earnings Growth

Operating Cash Flow (M)

-103.57

Levered Free Cash Flow (M)

-58.46

FoxReading.com

Valuation

P/E

-2.09

P/E Growth Ratio

0.01

P/BV

2.49

P/S

3.63

P/CF

-2.90

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.